Clinical trials conducted by Compass Pathways showed an approximately 40 to 45 percent response rate for psilocybin therapy in treatment-resistant depression
Agree
Disagree
Overview
Debates
Related claims
Topics
B
b5a31f81
Topic
Clinical trials
232
claims
·
240
news stories
0
B
b5a31f81
Topic
Psilocybin
44
claims
·
4
news stories
0
B
b5a31f81
Topic
Psychedelics for depression
24
claims
·
2
news stories
0
Opening sign-in…